Search JIM
Advanced Search
Journal of Chinese Integrative Medicine ›› 2004, Vol. 2 ›› Issue (1): 72-74.doi: 10.3736/jcim20040127
• Review • Previous Articles Next Articles
Hong-sheng Lin
CLC Number:
| [1] | 刘永隆, 房其年, 张秀琴 , 等. 金荞麦有效成分的研究[J]. 药学学报, 1983,18(7):545-547 |
| [2] | 张雯洁, 李兴从, 刘玉青 , 等. 威麦宁的酚性成分[J]. 云南植物研究, 1994,16(4):354-356 |
| [3] | 姚荣成, 吴友仁, 杨崇仁 , 等. 云南产金荞麦根茎抗肿瘤有效部位的化学研究[J]. 云南植物研究, 1989,11(2):215-218 |
| [4] | Okuda T, Mori K, Hatano T . Relationship of the structures of tannins to the binding activities with hemoglobin and methylene blue[J]. Chem Pharm Bull (Tokyo), 1985,33(4):1424-1433 |
| [5] |
Kakiuchi N, Hattori M, Namba T , et al. Inhibitory effect of tannins on reverse transcriptase from RNA tumor virus[J]. J Nat Prod, 1985,48(4):614-621
doi: 10.1021/np50040a016 pmid: 2413172 |
| [6] | 梁明达, 贾伟, 杨丽 , 等. 金荞麦根素体外抗癌作用的研究[J]. 云南医药, 1991,12(6):364-369 |
| [7] | 孟凡虹, 包群, 高倬 . 金荞麦根体外培养人肿瘤细胞的抗癌研究[J]. 昆明医学院学报, 1994,15(2):18-23 |
| [8] |
Chan PK . J.Inhibition of tumor growth in vitro by the extract of Fagopyrum cymosum(fago-c)[J]. Life Sci, 2003,72(16):1851-1858
doi: 10.1016/S0024-3205(03)00013-4 pmid: 12586222 |
| [9] | 刘红岩, 韩锐 . 金荞麦提取物抑制肿瘤细胞侵袭、转移和HT-1080细胞产生Ⅳ型胶原酶的研究[J]. 中国药理学通报, 1998,14(1):36-39 |
| [10] | 徐国辉, 合天惠, 周贵华 , 等. 金荞麦根的抗癌实验研究[J]. 中草药, 1982,13(4):48 |
| [11] | 杨体模, 荣祖元, 许世跃 , 等. 金荞麦E药理作用的研究[J]. 中国药理通讯, 1988,5(3):24 |
| [12] | 马云鹏, 程佳, 傅晓沧 , 等. 金荞麦提取物治疗肺癌的临床前预测研究[J]. 中国肿瘤临床, 1989,16(5):309-312 |
| [13] | 董玉宁, 于曦, 段丹丽 , 等. 威麦宁抑制DENA诱发小鼠肺肿瘤发生的实验研究[J]. 四川肿瘤防治, 1996,9(1):5-8 |
| [14] | 杨体模, 荣祖元, 吴友仁 . 金荞麦E对小鼠网状内皮系统吞噬功能的影响[J]. 四川生理科学杂志, 1992,14(1):9-12 |
| [15] | 傅体辉, 谢之容, 吴友仁 , 等. 威麦宁增强荷瘤小鼠脾LAK活性的实验研究[J]. 中国实验临床免疫学杂志, 1994,6(1):43-45 |
| [16] | 印德贤, 林树楠 . 金荞麦对小鼠腹腔巨噬细胞吞噬功能的影响[J]. 首都医药, 1999,6(12):28-29 |
| [17] | 马云鹏, 程佳, 席宁 , 等. 金E与肿瘤细胞DNA作用模式的探讨[J]. 中华肿瘤杂志, 1989,11(2):95-97 |
| [18] | Samel D , Donnella-Deana A, de Witte P.The effect of purified extract of Fagopyrum esculentum(buckwheat) on protein kinases involved in signal transduction pathways[J]. Planta Med, 1996,62(2):106-110 |
| [19] | .[ 申文江 . 威麦宁胶囊与放疗联合治疗中晚期肺癌的临床研究[A]. 见: 吴一龙主编. 中国临床肿瘤学教育专辑[M]. 广州: 中山大学出版社, 2002,96-100. |
| [1] | Huo-jun Zhang, Ji-jin Yang, Wei-xing Wang, Xu Jiang, Yan-jun Mao, Chao-ai Yang, Ji-xiang Guo. Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy. Journal of Chinese Integrative Medicine, 2008, 6(9): 907-910. |
| [2] | Zhi-qiang Pan, Zhao-qin Fang, Wen-li Lu, Chao Liang, Zhong-hua Wu, Xiao-mei Liu, Li Hou, Hui Zhang, Shao-yuan Zhuo, Ming-juan Liao, Bi-feng Gao. Differentially expressed genes in adrenal gland of H22 liver cancer mice with different syndromes and in different stages. Journal of Chinese Integrative Medicine, 2008, 6(8): 843-851. |
| [3] | Zhi-jun Dai, Xi-jing Wang, Zong-zheng Ji, Zong-fang Li, Wei Tang, Hua-feng Kang, Xiao-bin Ma, Lei Liu. Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(7): 720-724. |
| [4] | Hong-yun Chen, Zhe Chen. Transcatheter arterial chemoembolization combined with other therapies for the treatment of primary hepatic carcinoma: a review. Journal of Chinese Integrative Medicine, 2008, 6(4): 422-426. |
| [5] | Zhao-cheng Zhu, Qing-bo Lang, Zhe Chen, Dong-tao Li, Chang-quan Ling. Evaluation of Chinese version of the Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire. Journal of Chinese Integrative Medicine, 2008, 6(4): 341-345. |
| [6] | Hai-bo Yu, Cheng-en Pan, Wu-jun Wu, Si-hai Zhao, Hui-feng Zhang. Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells. Journal of Chinese Integrative Medicine, 2008, 6(3): 270-273. |
| [7] | A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82. |
| [8] | Chen Zhang, Bai Li, Shu-qin Lu, Yong Li, Yong-hua Su, Chang-quan Ling. Effects of melittin on expressions of mitochondria membrane protein 7A6, cell apoptosis-related gene products Fas and Fas Ligand in hepatocarcinoma cells. Journal of Chinese Integrative Medicine, 2007, 5(5): 559-563. |
| [9] | Ju-yong Wang, Zhen-ye Xu. Effects of NK-104 on apoptosis and caspase-3 activity in hepatocellular carcinoma cells. Journal of Chinese Integrative Medicine, 2007, 5(3): 298-301. |
| [10] | Wei Gu, Ke-qi Han, Yong-hua Su, Xue-qiang Huang, Chang-quan Ling. Inhibition action of bufalin on human transplanted hepatocellular tumor and its effects on expressions of Bcl-2 and Bax proteins in nude mice. Journal of Chinese Integrative Medicine, 2007, 5(2): 155-159. |
| [11] | Qi Li, Zhong-ze Fan, Xian-qian Li, Xiao-hua Liu, Jue Sun, Wei Gu, Paul Heng, Hong Gao. Effects of interventional therapy with norcantharidin microsphere on hepatoma in rats and its mechanism. Journal of Chinese Integrative Medicine, 2006, 4(4): 378-383. |
| [12] | Wei Gu, Ya-ni Zhang, Bai Li, Jie Han, Bin-bin Cheng, Chang-quan Ling. Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics. Journal of Chinese Integrative Medicine, 2006, 4(3): 265-270. |
| [13] | Li-xia Ju, Zhe Chen, Rong-zheng Ren. Progress in research on the treatment of primary liver cancer with traditional Chinese medicine for activating blood to resolve stasis. Journal of Chinese Integrative Medicine, 2005, 3(6): 491-494. |
| [14] | Jian-xiong Zhao, Wei-dong Cheng, Rui-feng Xu, Yuan-qing Li. Effects of Fuzheng Yiliu Granule-medicated serum on apoptosis of liver cancer cells from mice and its mechanism. Journal of Chinese Integrative Medicine, 2005, 3(4): 278-281. |
| [15] | Qing Liu, Yan-bo Zhang, Chuan-hong Ma, Xiao-qiang Yue, Chang-quan Ling. Analysis of literature on therapeutic methods and medicines of traditional Chinese medicine for primary liver cancer. Journal of Chinese Integrative Medicine, 2005, 3(4): 260-262. |
|
沪公网安备31010602003416号 沪ICP备18017633号-3